AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

COCHLEAR LTD

275.860

+2.2600.83%

Volume:46.64K

Turnover:12.85M

Market Cap:18.04B

PE:48.90

High:277.450

Open:273.690

Low:271.000

Close:273.600

Loading ...

Overview Company News Filings

Cochlear Named Most Trustworthy Healthcare Company in the World

Cochlear's (ASX:COH) earnings growth rate lags the 6.1% CAGR delivered to shareholders

Simply Wall St.

Buy Hold Sell: 12 key ASX stocks and the important themes from reporting season

Cochlear North America Celebrates International Cochlear Implant Day by Announcing 2025 Academic Scholarship Winners

Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching

Simply Wall St.

Should you buy the dip on ASX healthcare stocks CSL, Cochlear and Pro Medicus?

Here are the top 10 ASX 200 shares today

Cochlear's Fiscal H1 Results Miss 'Disappointing,' Jarden Research Says

MT Newswires Live

Cochlear's Slump Leaves Shares Fairly Valued -- Market Talk

Cochlear Shakes Off Bear Following Share-Price Dive -- Market Talk

The Cochlear share price hit a 52-week low last week, is it time to buy?

Cochlear First Half 2025 Earnings: Revenues Disappoint

Simply Wall St.

ASX Weekly Review｜Shares Reset Peak; Computershare Surges 21%; Cochlear Plunges 15%

Weekly wrap: record high market overcomes tariff fears

Jefferies Upgrades Cochlear to Buy from Hold; Price Target is AU$308

MT Newswires Live

Cochlear Ltd (CHEOF) (H1 2025) Earnings Call Highlights: Strong Implant and Acoustics Revenue ...

ASX Market Close: Index finished the week on a high | February 14, 2025

The Market Herald

BUZZ-Australia's Cochlear slumps as HY results, outlook disappoint

ASX Midday Sector Update: Utilities Sector Rises, Healthcare Struggles

MT Newswires Live

Why AMP, Civmec, Cochlear, and LGI shares are falling today

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/COH.AU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"COH.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COH.AU\",,,,,undefined,":{"symbol":"COH.AU","market":"AU","secType":"STK","nameCN":"COCHLEAR LTD","latestPrice":275.86,"timestamp":1746159467701,"preClose":273.6,"halted":0,"volume":46635,"delay":0,"nameEN":"COCHLEAR LTD","floatShares":65138291,"shares":65396930,"eps":5.641558,"marketStatus":"Trading","change":2.26,"latestTime":"05-02 14:17:48 AEST","open":273.69,"high":277.45,"low":271,"amount":12850683,"amplitude":0.023575,"askPrice":275.93,"askSize":3,"bidPrice":275.86,"bidSize":14,"shortable":3,"etf":0,"ttmEps":5.641558,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1746165600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":273.6,"dividendRate":0.015406,"openAndCloseTimeList":[[1746144000000,1746165600000]],"volumeRatio":0.376117,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COH.AU\",,,,,undefined,":{"symbol":"COH.AU","floatShares":65138291,"roa":"12.28%","roe":"20.30%","lyrEps":5.444277,"volumeRatio":0.376117,"shares":65396930,"dividePrice":4.25,"high":277.45,"amplitude":0.023575,"preClose":273.6,"low":271,"week52Low":246.14,"pbRate":"9.66","psRate":"7.81","week52High":344.999,"institutionHeld":0,"latestPrice":275.86,"committee":0.647059,"eps":5.641558,"divideRate":0.015406,"volume":46635,"delay":0,"ttmEps":5.641558,"open":273.69,"prevYearClose":287.567,"prevWeekClose":264.62,"prevMonthClose":274.59,"prevQuarterClose":262.3,"fiveDayClose":264.62,"twentyDayClose":265.01,"sixtyDayClose":309.957},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"COH.AU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516763579","title":"Cochlear Named Most Trustworthy Healthcare Company in the World","url":"https://stock-news.laohu8.com/highlight/detail?id=2516763579","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516763579?lang=en_us&edition=fundamental","pubTime":"2025-03-03 21:20","pubTimestamp":1741008000,"startTime":"0","endTime":"0","summary":"LONE TREE, Colo., March 3, 2025 /PRNewswire/ --In celebration of World Hearing Day, Cochlear, the global leader in implantable hearing solutions, is proud to announce that it has been named the number one most trustworthy company in the healthcare industry by Newsweek in its 2024 rankings of the World's Most Trustworthy Companies. This prestigious recognition underscores Cochlear's unwavering commitment to excellence, innovation, and customer-centricity.The Newsweek ranking was conducted independently in collaboration with global data research firm Statista and evaluated companies based on customer, investor, and employee trust. Over 70,000 participants provided 269,000 evaluations, highlighting Cochlear's exceptional reputation and dedication to improving the lives of those with hearing loss.Cochlear has a global workforce of over 5,000 people, with a passion for progress, who strive to meet the needs of people living with hearing loss. The company continually innovates to anticipate ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance_au","url":"https://finance.yahoo.com/news/cochlear-named-most-trustworthy-healthcare-132000686.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cochlear-named-most-trustworthy-healthcare-132000686.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK4137","COH.AU","HCSG","BK7007"],"gpt_icon":0},{"id":"2516560279","title":"Cochlear's (ASX:COH) earnings growth rate lags the 6.1% CAGR delivered to shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2516560279","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516560279?lang=en_us&edition=fundamental","pubTime":"2025-03-02 08:31","pubTimestamp":1740875501,"startTime":"0","endTime":"0","summary":"Cochlear Limited  shareholders have seen the share price descend 19% over the month. But at least the stock is up over the last five years. In that time, it is up 26%, which isn't bad, but is below the market return of 62%.Although Cochlear has shed AU$654m from its market cap this week, let's take a look at its longer term fundamental trends and see if they've driven returns.While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share  with the share price movement.The graphic below depicts how EPS has changed over time .","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cochlears-asx-coh-earnings-growth-003141474.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["COH.AU"],"gpt_icon":0},{"id":"2514355828","title":"Buy Hold Sell: 12 key ASX stocks and the important themes from reporting season","url":"https://stock-news.laohu8.com/highlight/detail?id=2514355828","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514355828?lang=en_us&edition=fundamental","pubTime":"2025-02-28 04:00","pubTimestamp":1740686422,"startTime":"0","endTime":"0","summary":"Whether you're a fund manager overseeing billions or a Livewire reader investing your hard-earned money, there is no better time than the end of reporting season.Firstly, because it’s bloody exhausting, and secondly, because it’s the clearest picture you will ever get of the health of corporate Australia and the shape of your own portfolio.Right now is the moment where there is the least noise, the least speculation, and the least fluff. This moment allows investors to make some intelligent decisions, with the fullest information possible, about which opportunities they want to pursue, and forgo, over the coming six months.So, what were the key themes from the season?And, more importantly, which stocks crushed it - and which got crushed?To help answer those questions, Livewire’s James Marlay sat down with James Gerrish from Market Matters and Jun Bei Liu from Tencap for this special February 2025 reporting season wrap-up of Buy Hold Sell.Note: This episode was recorded on Thursday, 26 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/buy-hold-sell-12-key-asx-stocks-and-the-important-themes-from-reporting-season","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/buy-hold-sell-12-key-asx-stocks-and-the-important-themes-from-reporting-season","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BK7141","ABB.AU","MIN.AU","BK7093","BK7099","LOV.AU","A2M.AU","WTC.AU","BK7054","APA.AU","TLS.AU","BK7503","COH.AU","BK7002","BK7095","HUB.AU","BK7510","BK7007","BK7016","BK7155","REA.AU","BK7015","BK7128","BK7504","BK7042","GMG.AU","BK7505","BK7507","BK7511","ZIP.AU","BK7148"],"gpt_icon":0},{"id":"2514011852","title":"Cochlear North America Celebrates International Cochlear Implant Day by Announcing 2025 Academic Scholarship Winners","url":"https://stock-news.laohu8.com/highlight/detail?id=2514011852","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514011852?lang=en_us&edition=fundamental","pubTime":"2025-02-26 00:12","pubTimestamp":1740499920,"startTime":"0","endTime":"0","summary":"LONE TREE, Colo., Feb. 25, 2025 /PRNewswire/ --In celebration of International Cochlear Implant Day, Cochlear North America is thrilled to announce the winners of 2025 annual Cochlear Academic Scholarships. Eight outstanding recipients of either the Cochlear Nucleus Implant, Cochlear Baha System and Cochlear Osia System have been chosen for their abilities to uphold the Cochlear ideals of leadership and humanity, as well as demonstrate high academic achievement.Emily E., from Decatur, AL, is studying Speech-Language Pathology at the University ofMontevallo. Born profoundly deaf with Pendred Syndrome, Emily has overcome significant challenges with the help of her cochlear implant. Her experiences have inspired her to pursue a career in audiology, where she hopes to serve as a role model and advocate for others with cochlear implants.Sophie G., from St. Johns, FL, is attending Florida State University. Sophie's journey with cochlear implants has been marked by her determination to overco","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance_au","url":"https://finance.yahoo.com/news/cochlear-north-america-celebrates-international-161200332.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cochlear-north-america-celebrates-international-161200332.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["COH.AU","BK7007"],"gpt_icon":0},{"id":"2513791063","title":"Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching","url":"https://stock-news.laohu8.com/highlight/detail?id=2513791063","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513791063?lang=en_us&edition=fundamental","pubTime":"2025-02-24 07:38","pubTimestamp":1740353890,"startTime":"0","endTime":"0","summary":"It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/heres-why-we-think-cochlear-asxcoh-is-well-worth-watching-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["COH.AU","BK7007","EBIT"],"gpt_icon":0},{"id":"2512979589","title":"Should you buy the dip on ASX healthcare stocks CSL, Cochlear and Pro Medicus?","url":"https://stock-news.laohu8.com/highlight/detail?id=2512979589","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512979589?lang=en_us&edition=fundamental","pubTime":"2025-02-18 05:00","pubTimestamp":1739826009,"startTime":"0","endTime":"0","summary":"In this article, we’ll investigate the best and worst bits of the recent first-half financial year 2025 results  releases of three of the ASX’s premier healthcare companies, CSL Limited , Cochlear , and Pro Medicus .We’ll also check out the market’s response to the results, including the dip in each of their share prices, as well as all the changes in major brokers’ ratings and target prices. Do the experts think you should buy the dip on these blue-chip ASX healthcare stocks?CSL is a true Australian success story, having grown from humble beginnings as Commonwealth Serum Laboratories founded in 1916, to a globally significant healthcare company. It operates across the world with divisions including CSL Behring , CSL Seqirus , and CSL Vifor .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/should-you-buy-the-dip-on-asx-healthcare-stocks-csl-cochlear-and-pro-medicus","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/should-you-buy-the-dip-on-asx-healthcare-stocks-csl-cochlear-and-pro-medicus","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["LU0205194284.USD","CSL","LU0061475181.USD","LU2471134879.HKD","CSL.AU","IE0004086264.USD","SG9999004303.SGD","LU2237443549.SGD","SGXZ23171101.USD","COH.AU","BK7501","LU0106831901.USD","XKO.AU","BK7067","BK4516","LU2237438978.USD","LU1868836757.USD","PME.AU","LU0728928796.USD","BK4127","LU2237443465.HKD","LU0205193047.USD","LU2237443978.SGD","LU1791807156.HKD","BK4086","LU1868836591.USD","XJO.AU","IE00B19Z3B42.SGD","LU1868836914.USD","BK4504","BK7508","LU1868837300.USD","LU0106261612.USD","LU2471134523.USD","LU1668664300.SGD","IE00B64QTZ34.USD","XAO.AU","IE00B19Z3581.USD","BK7094","LU2471134796.USD","BK4585","LU2471134952.CNY","LU2750360641.GBP","BK4552","LU1169589451.USD","LU2237443382.USD","BK4550","LU1868837136.USD","LU0012050646.USD","HAE"],"gpt_icon":0},{"id":"2512947059","title":"Here are the top 10 ASX 200 shares today","url":"https://stock-news.laohu8.com/highlight/detail?id=2512947059","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512947059?lang=en_us&edition=fundamental","pubTime":"2025-02-17 14:20","pubTimestamp":1739773255,"startTime":"0","endTime":"0","summary":"It was a rough start to the trading week for the S&P/ASX 200 Index (ASX: XJO) this Monday. After an extraordinary week last week which saw the ASX 200 hit a new all-time high, the index went backwards","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/17/here-are-the-top-10-asx-200-shares-today-17-february-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["AGR.AU","BK7129","BK7007","BK7103","BK7510","ZIP.AU","BSL.AU","BK7087","XJO.AU","COH.AU","SIG.AU","BK7095","MGR.AU","AD8.AU","A2M.AU","BK7141","GPT.AU","BK7503","BK7093","BK7137","GYG.AU","BK7505","BK7073"],"gpt_icon":1},{"id":"2512996179","title":"Cochlear's Fiscal H1 Results Miss 'Disappointing,' Jarden Research Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2512996179","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512996179?lang=en_us&edition=fundamental","pubTime":"2025-02-17 12:11","pubTimestamp":1739765462,"startTime":"0","endTime":"0","summary":"Cochlear  first half-results missing estimates is \"disappointing\" due to upgrades to its Nuclear 8 sound processor, which caused a decline in services revenue, according to Feb. 14 noted by Jarden Research.The company reported Friday that its six-month earnings per diluted share rose to AU$3.125 from AU$2.913 per diluted share a year earlier. Total revenue for the half year ended Dec. 31, 2024, was AU$1.17 billion.Jarden believes that COH's plan to launch its next-generation implant and the introduction of its Kanso 3 sound processor by mid-2025 should strengthen its outlook for 2026.The investment firm reaffirmed a neutral rating and a price target of AU$263.75 on COH.Shares of COH rose 4% in recent Monday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","COH.AU"],"gpt_icon":0},{"id":"2512966016","title":"Cochlear's Slump Leaves Shares Fairly Valued -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2512966016","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512966016?lang=en_us&edition=fundamental","pubTime":"2025-02-17 08:38","pubTimestamp":1739752680,"startTime":"0","endTime":"0","summary":"0038 GMT - Cochlear looks fairly valued to Macquarie analysts following the share-price slump that followed the hearing-implant maker's first-half result. The analysts tell clients in a note that while December-half group unit sales and services revenue fell short of market expectations, there were still things to like about the Australia-listed company's latest update. Developed-market unit sales were up 6% on year on demand from adults and seniors, while group unit sales are still expected to grow by 10% going forward. EBIT was slightly higher than the Macquarie analysts had anticipated thanks to lower costs. Target price falls 2.4% to A$282.15 but Macquarie stays neutral on the stock, which is up 2.8% at A$270.11. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","COH.AU"],"gpt_icon":0},{"id":"2512963397","title":"Cochlear Shakes Off Bear Following Share-Price Dive -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2512963397","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512963397?lang=en_us&edition=fundamental","pubTime":"2025-02-17 07:25","pubTimestamp":1739748300,"startTime":"0","endTime":"0","summary":"2325 GMT - Cochlear shakes off its bear at UBS thanks to the 14% share-price dive that followed the hearing-implant maker's 1H result. Analyst Laura Sutcliffe raises her recommendation on the Australia-listed stock to neutral from sell, telling clients in a note that the result wasn't as bad as it looked. She isn't totally convinced by the company's expectation of 10% implant unit growth in the June half, calling it a big ask. However, she sees Cochlear's confidence in such a growth rate going forward as important. UBS lifts its target price 5.6% to A$285.00. Shares are up 2.6% at A$269.64. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COH.AU","BK7007"],"gpt_icon":0},{"id":"2512296860","title":"The Cochlear share price hit a 52-week low last week, is it time to buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2512296860","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512296860?lang=en_us&edition=fundamental","pubTime":"2025-02-17 05:46","pubTimestamp":1739742391,"startTime":"0","endTime":"0","summary":"After seeing the result, the broker UBS suggested the result was less bad than it looked. The broker noted that the Cochlear implant unit growth was 6% year over year with stable pricing. The company continues to expect growth of around 10% for FY25, implying an uplift in the second half. It also sees this as a \"sustainable forward run rate\". While near-term profit is not expected to be as good, the broker increased its net profit forecasts in the mid-single digits in the long term based on the Cochlear implant sales forecasts. This helped improve the price target on the Cochlear share price to A$285. A price target is what the broker sees the share price being in 12 months. However, UBS noted that Cochlear \"still faces the prospect of a vaccine against CMV, a major cause of neonatal deafness, developed by Moderna. There is no phase III trial data yet, but it's a risk for the second half. UBS estimates at least 30% of Cochlear's implants in the US are for children at the moment. Commen","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/17/the-cochlear-share-price-hit-a-52-week-low-last-week-is-it-time-to-buy/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["COH.AU","BK7007"],"gpt_icon":0},{"id":"2511607235","title":"Cochlear First Half 2025 Earnings: Revenues Disappoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2511607235","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511607235?lang=en_us&edition=fundamental","pubTime":"2025-02-16 06:40","pubTimestamp":1739659205,"startTime":"0","endTime":"0","summary":"ASX:COH Earnings and Revenue Growth February 15th 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue missed analyst estimates by 2.6%. Earnings per share  was mostly in line with analyst estimates.Looking ahead, revenue is forecast to grow 9.0% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Medical Equipment industry in Australia.The company's shares are down 15% from a week ago.Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We have a graphic representation of Cochlear's balance sheet and an in-depth analysis of the company's financial position.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cochlear-first-half-2025-earnings-224005868.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["COH.AU"],"gpt_icon":0},{"id":"1150263408","title":"ASX Weekly Review｜Shares Reset Peak; Computershare Surges 21%; Cochlear Plunges 15%","url":"https://stock-news.laohu8.com/highlight/detail?id=1150263408","media":"TigerNews AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150263408?lang=en_us&edition=fundamental","pubTime":"2025-02-15 08:45","pubTimestamp":1739580300,"startTime":"0","endTime":"0","summary":"Australian shares reset a record closing high on Friday, shrugging off fears around US reciprocal tariffs and a minor sell-off in Commonwealth Bank shares that hit the bourse.The S&P/ASX 200 index ros","market":null,"thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XJO.AU","COH.AU","NEC.AU","XKO.AU","XAO.AU","CBA.AU","CPU.AU","ORG.AU","S32.AU"],"gpt_icon":1},{"id":"2511641039","title":"Weekly wrap: record high market overcomes tariff fears","url":"https://stock-news.laohu8.com/highlight/detail?id=2511641039","media":"Small Caps","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511641039?lang=en_us&edition=fundamental","pubTime":"2025-02-15 06:34","pubTimestamp":1739572456,"startTime":"0","endTime":"0","summary":"Fears of fresh tariffs were not enough to hold back the Australian share market which closed at a record high on Friday.The ASX 200 index closed up 0.2% or 15.8 points to reach the new closing record of 8555.8 points, in the process also overcoming a minor fall for the market leading Commonwealth Bank and a slump by Cochlear.The rise meant the ASX 200 added an impressive 0.5% during a week that was dominated by fresh fears of a trade war as US President Trump once again showed that when it comes to trade, there is no such thing as an ally.He even decided to target value added taxes for reciprocal tariffs on trading partners such as Australia’s GST which could result in further tariff pain for Australia despite our close security arrangement with the US and the AUKUS defence arrangements.The record was made even more impressive by a rally in the Australian dollar which hit a two-month high of US63.28c.Shares in fellow liquor company Endeavour Group  also rose 4% to $4.42.","market":"us","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/02/Feb-2025-market.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/02/Feb-2025-market.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/weekly-wrap-record-high-market-overcomes-tariff-fears/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["BK7130","WBC.AU","COH.AU","XAO.AU","BK7040","BK7507","BK7505","XKO.AU","BK7103","BK7104","BK7135","SIG.AU","BK7511","BK7082","CBA.AU","EDV.AU","BK7501","BGL.AU","BK7112","ANZ.AU","BK7007","COL.AU","XJO.AU","BK7006","NAB.AU","BK7097","TWE.AU","AMP.AU","WOW.AU","ORG.AU"],"gpt_icon":1},{"id":"2511652956","title":"Jefferies Upgrades Cochlear to Buy from Hold; Price Target is AU$308","url":"https://stock-news.laohu8.com/highlight/detail?id=2511652956","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511652956?lang=en_us&edition=fundamental","pubTime":"2025-02-14 17:19","pubTimestamp":1739524751,"startTime":"0","endTime":"0","summary":"Cochlear (ASX:COH) has an average rating of hold and price targets ranging from AU$225 to AU$345, according to analysts polled by Capital IQ.(MT Newswires covers equity, commodity and economic researc","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["COH.AU"],"gpt_icon":0},{"id":"2511655061","title":"Cochlear Ltd (CHEOF) (H1 2025) Earnings Call Highlights: Strong Implant and Acoustics Revenue ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2511655061","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511655061?lang=en_us&edition=fundamental","pubTime":"2025-02-14 15:24","pubTimestamp":1739517854,"startTime":"0","endTime":"0","summary":"Revenue Growth: Overall net sales increase of 6% in constant currency.Cochlear Implant Revenue: Increased by 13% with unit growth of 6%.Underlying Net Profit: Increased by 7% to $206 million.Cash Position: $383 million, decreased due to inventory buildup.Inventory Increase: $69.5 million increase due to new product launches.Cloud Investment: $11.7 million in H1, expected $40 million for the full year.GuruFocus has detected 2 Warning Sign with CHEOF.Cochlear Ltd  reported a 13% increase in Cochlear implant revenue and a 22% rise in Acoustics revenue, contributing to a 6% net sales increase in constant currency.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cochlear-ltd-cheof-h1-2025-072414683.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["CHEOF","COH.AU"],"gpt_icon":0},{"id":"2511653216","title":"ASX Market Close: Index finished the week on a high | February 14, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2511653216","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511653216?lang=en_us&edition=fundamental","pubTime":"2025-02-14 14:08","pubTimestamp":1739513280,"startTime":"0","endTime":"0","summary":"The ASX200 closed up 0.19% at 8,555 points.The Aussie index flirted with yet again breaking its all-time record as investor enthusiasm builds on the eve of the RBA’s rate decision next week.The Australian dollar continues to recover and has been trading at 63.2 cents.Staples was the best performing sector, up 1.9%, followed by IT, up 1%, and Discretionary, up 0.75%.Energy was the worst performer, down 0.7%, followed by Financials and Health Care – both down around 0.25%.Siren Gold closed up 3.3% after flagging drilling at the Sams Creek Project at the top ofNew Zealand’s South Island in Golden Bay.GQG Partners  closed up 2.9% on its full-year results. The company chalked up a 50.4% increase in net operating income, to US$578 million.Macarthur Mineralsclosed down 5.1% after releasing an update. The reports for the nine months ending December 31 revealed a net loss of $25.6 million.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-close-index-finished-the-week-on-a-high-february-14-2025-2025-02-14/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7104","FFM.AU","MIO.AU","COH.AU","GQG.AU","SNG.AU","BK7062","BMG.AU","BK7095","BK7007"],"gpt_icon":0},{"id":"2511824346","title":"BUZZ-Australia's Cochlear slumps as HY results, outlook disappoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2511824346","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511824346?lang=en_us&edition=fundamental","pubTime":"2025-02-14 11:39","pubTimestamp":1739504392,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Cochlear slumps as HY results, outlook disappointUpdates with comments from UBS note** Cochlear COH.AX slides as much as 14.1% to A$261.73; set for worst day since March 2020. ** Hearing implants maker reports HY underlying NPAT of A$206 mln , missing Visible Alpha consensus of A$209.3 mln** Expects FY underlying net profit to be at lower end of A$410 mln-A$430 mln forecast range** UBS says, \"New expectations for being at lower end of profit guidance could cause concern or it could just be a blip if services revenue in fiscal 2026 can pick up again with new product launches\"** Expects single-digit decline in FY services revenue** COH among worst performers on ASX 200 benchmark index .AXJO** Stock, one of the priciest in the country, down ~9% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250214:nL4N3P5085:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0354030511.USD","LU2095319765.USD","BK4581","LU1988902786.USD","LU2264538146.SGD","LU2023251221.USD","SG9999014880.SGD","LU2764263039.SGD","LU1989764748.USD","BK4597","LU1496350502.SGD","GB00BDT5M118.USD","SGXZ31699556.SGD","BK4585","LU0868494617.USD","LU1804176565.USD","LU0154236417.USD","BK4588","LU0985320562.USD","LU1363072403.SGD","LU0342679015.USD","LU1989772840.SGD","BK4534","LU1633808545.USD","LU1064131342.USD","LU1989772923.USD","SG9999001077.SGD","LU0097036916.USD","LU2111349929.HKD","SG9999014906.USD","LU0354030438.USD","LU0158827948.USD","LU0345774631.USD","BK7007","SPGI","LU2028103732.USD","LU1989773731.SGD","SG9999018865.SGD","SG9999017495.SGD","LU2720916845.USD","LU0971096721.USD","LU2210149790.SGD","COH.AU","IE00B19Z9505.USD","BK4112","LU1496350171.SGD","LU0345774391.USD","LU2764263203.CNY","BK4548","LU1989764664.SGD"],"gpt_icon":0},{"id":"2511265689","title":"ASX Midday Sector Update: Utilities Sector Rises, Healthcare Struggles","url":"https://stock-news.laohu8.com/highlight/detail?id=2511265689","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511265689?lang=en_us&edition=fundamental","pubTime":"2025-02-14 10:42","pubTimestamp":1739500967,"startTime":"0","endTime":"0","summary":"The utilities sector rose 1.6% at midday Friday. Investors opted for defensive stocks after US President Donald Trump announced on US trading partners.LGI  reported a fiscal 2025 first-half total revenue of AU$16.9 million, rising 7% compared to the prior corresponding period revenue of AU$15.9 million.On the other hand, healthcare stocks were trading in the red, falling 0.29%.Cochlear  shares fell past 13% in recent trade on Friday. It reported that its six-month earnings per diluted share rose to AU$3.125 from AU$2.913 per diluted share a year earlier.The medical device firm expects underlying net profit for the fiscal year at the lower end of the AU$410 million to AU$430 million guidance provided in August 2024.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LGI.AU","BK7060","HCSG","BK4137","BK7007","COH.AU"],"gpt_icon":0},{"id":"2511168267","title":"Why AMP, Civmec, Cochlear, and LGI shares are falling today","url":"https://stock-news.laohu8.com/highlight/detail?id=2511168267","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511168267?lang=en_us&edition=fundamental","pubTime":"2025-02-14 10:35","pubTimestamp":1739500547,"startTime":"0","endTime":"0","summary":"TheS&P/ASX 200 Index(ASX: XJO) is on course to end the week on a positive note. In afternoon trade, the benchmark index is up 0.5% to 8,583 points. Four ASX shares that have failed to follow the marke","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/14/why-amp-civmec-cochlear-and-lgi-shares-are-falling-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["IE00BGHQF748.EUR","LU1791807156.HKD","AMP.AU","LU1668664300.SGD","CVL.AU","BK7055","BK4135","LU0106831901.USD","BK7112","IE00B3QW5Z07.USD","BK7060","COH.AU","BK4588","BK4585","LU2108987350.USD","IE00B64PRP62.GBP","BK7007","LGI","AMP","LGI.AU","XJO.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":3,"totalSize":105,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/COH.AU\",params:#limit:5,,,undefined,":[{"date":"2025-03-20","symbol":"COH.AU","amount":2.15,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-03-21","name":"COCHLEAR LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-14","payableDate":"2025-03-21","currency":"AUD","dateTimestamp":1742389200000,"payDate":"2025-04-14"},{"date":"2025-02-13","symbol":"COH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739401200000,"name":null,"time":"","dateTimestamp":1739365200000,"actualEps":null},{"date":"2024-09-17","symbol":"COH.AU","amount":2.1,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-09-18","defaultRemindTime":1726531200000,"name":"COCHLEAR LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-10","payableDate":"2024-09-18","currency":"AUD","dateTimestamp":1726495200000,"payDate":"2024-10-10"},{"date":"2024-08-15","symbol":"COH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723680000000,"name":null,"time":"","dateTimestamp":1723644000000,"actualEps":null},{"date":"2024-03-21","symbol":"COH.AU","amount":2,"announcedDate":"2024-02-19","type":"dividend","market":"AU","newRecordDate":"2024-03-22","defaultRemindTime":1710975600000,"name":"科利耳有限公司","recordDate":"2024-04-15","payableDate":"2024-03-22","currency":"AUD","dateTimestamp":1710939600000,"payDate":"2024-04-15"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"COH.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2021-03-25","recordDate":"2021-03-26","paymentDate":"2021-04-20","value":1.15,"currency":"AUD"},{"executeDate":"2021-09-23","recordDate":"2021-09-24","paymentDate":"2021-10-18","value":1.4,"currency":"AUD"},{"executeDate":"2022-03-28","recordDate":"2022-03-29","paymentDate":"2022-04-21","value":1.55,"currency":"AUD"},{"executeDate":"2022-09-21","recordDate":"2022-09-23","paymentDate":"2022-10-17","value":0.87,"currency":"AUD"},{"executeDate":"2023-03-21","recordDate":"2023-03-22","paymentDate":"2023-04-14","value":1.0075,"currency":"AUD"}]}}